Gene Biotherapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of angiogenic gene therapy biotherapeutics for the treatment of cardiovascular diseases in the United States. The company's lead product candidate is Generx, an angiogenic gene therapy product candidate in Phase 3 clinical trials for the potential treatment of patients with myocardial ischemia and refractory angina due to advanced coronary artery disease. It is also developing Generx for ischemia-related cardiovascular and cerebral therapeutic indications. Gene Biotherapeutics, Inc. has an agreement with Fujifilm Diosynth Biotechnologies for the manufacture of Generx angiogenic gene therapy product for Phase 3 clinical evaluation. The company was formerly known as Taxus Cardium Pharmaceuticals Group, Inc. and changed its name to Gene Biotherapeutics, Inc. in January 2018. Gene Biotherapeutics, Inc. was incorporated in 2003 and is headquartered in San Diego, California. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Taxus Cardium Pharmaceuticals Group, Inc..
Taxus Cardium Pharmaceuticals Group, Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Taxus Cardium Pharmaceuticals Group, Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Taxus Cardium Pharmaceuticals Group, Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Taxus Cardium Pharmaceuticals Group, Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Taxus Cardium Pharmaceuticals Group, Inc. and all latest updates of the company are provided.
The 2025 version of Taxus Cardium Pharmaceuticals Group, Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Taxus Cardium Pharmaceuticals Group, Inc.- Key Facts
2.2 Taxus Cardium Pharmaceuticals Group, Inc.- Geographic Locations
2.3 Taxus Cardium Pharmaceuticals Group, Inc.- Subsidiaries and Affiliates
2.4 Taxus Cardium Pharmaceuticals Group, Inc.- Business Divisions
2.5 Taxus Cardium Pharmaceuticals Group, Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Taxus Cardium Pharmaceuticals Group, Inc. Strategic Analysis Review
3.1 Taxus Cardium Pharmaceuticals Group, Inc.- Key Strategies
3.2 Taxus Cardium Pharmaceuticals Group, Inc.- Company Outlook Statement
3.3 Taxus Cardium Pharmaceuticals Group, Inc.- SWOT Analysis
3.3.1 Taxus Cardium Pharmaceuticals Group, Inc.- Key Strengths
3.3.2 Taxus Cardium Pharmaceuticals Group, Inc.- Key Weaknesses
3.3.3 Taxus Cardium Pharmaceuticals Group, Inc.- Potential Opportunities
3.3.4 Taxus Cardium Pharmaceuticals Group, Inc.- Potential Threats
3.4 Taxus Cardium Pharmaceuticals Group, Inc.- Key Competitors
4. Business Description of the Company
4.1 Taxus Cardium Pharmaceuticals Group, Inc.- Business Overview
4.2 Taxus Cardium Pharmaceuticals Group, Inc.- Operations by Segment
5 Products and Services Details
5.1 Taxus Cardium Pharmaceuticals Group, Inc.- Key Products
5.2 Taxus Cardium Pharmaceuticals Group, Inc.- Key Service Areas
5.3 Taxus Cardium Pharmaceuticals Group, Inc.- Key Brands
6 Company Developments
6.1 Taxus Cardium Pharmaceuticals Group, Inc.- Company History
6.2 Taxus Cardium Pharmaceuticals Group, Inc.- Latest Developments
7 Financial Analysis
7.1 Taxus Cardium Pharmaceuticals Group, Inc.- Income Statements
7.2 Taxus Cardium Pharmaceuticals Group, Inc.- Balance Sheet
7.3 Taxus Cardium Pharmaceuticals Group, Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Taxus Cardium Pharmaceuticals Group, Inc.- Direct Competitors
8.2 Taxus Cardium Pharmaceuticals Group, Inc.- Competitor Financial Ratios comparison
8.3 Taxus Cardium Pharmaceuticals Group, Inc.- Competitor Stock Charts Comparison
8.4 Taxus Cardium Pharmaceuticals Group, Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!